Zevra Therapeutics Inc.

11/21/2024 | Press release | Distributed by Public on 11/21/2024 16:26

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C